David Hermann

5.0k citations

46 papers · 3.6k indexed · 2 hit papers · h-index 23

Impact in

Anesthesiology and Pain Medicine top 0.05%
- Anesthesia and Sedative Agents
Developmental Neuroscience top 0.5%
- Anesthesia and Neurotoxicity Research

Papers in ⓘ

Anesthesiology and Pain Medicine 8
- Anesthesia and Sedative Agents 8
Urology 5
- Urinary Bladder and Prostate Research 5

Co-authors: Keith T. Muir (9 shared papers)Steven L. Shafer (6 shared papers)Talmage D. Egan (6 shared papers)Harry J. M. Lemmens (3 shared papers)Charles F. Minto (4 shared papers)Jaap W. Mandema (3 shared papers)Thomas W. Schnider (2 shared papers)Elizabeth Youngs (2 shared papers)
Journals: Anesthesiology (8 papers)Journal of Pharmacokinetics and Pharmacodynamics (2 papers)Nature Medicine (2 papers)Combinatorial Chemistry & High Throughput Screening (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
Partner nations: United States United Kingdom South Africa

In The Last Decade

David Hermann

46 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil 1997 · 910 citations

Peers

Countries citing papers authored by David Hermann

Since Specialization

Citations

This map shows the geographic impact of David Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hermann more than expected).

Fields of papers citing papers by David Hermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hermann. The network helps show where David Hermann may publish in the future.

Co-authors

The 25 scholars most cited alongside David Hermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Hermann Line = papers co-authored together David Hermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil Anesthesiology ·Charles F. Minto, Thomas W. Schnider, Talmage D. Egan, Elizabeth Youngs, Harry J. M. Lemmens, Pedro L. Gambús, V. Billard, John F. Hoke, Katherine H. Moore, David Hermann, Keith T. Muir, Jaap W. Mandema, Steven L. Shafer Hit paper breakdown →	1997	910
2	The Pharmacokinetics of the New Short-acting Opioid Remifentanil (GI87084B) in Healthy Adult Male Volunteers Anesthesiology ·Talmage D. Egan, Harry J. M. Lemmens, Pierre Fiset, David Hermann, Keith T. Muir, Donald R. Stanski, Steven L. Shafer Hit paper breakdown →	1993	445
3	Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor The Journal of Clinical Endocrinology & Metabolism ·Richard V. Clark, David Hermann, Glenn R. Cunningham, Timothy H. Wilson, Betsy Morrill, S. F. Hobbs	2004	355
4	Remifentanil Versus Alfentanil Anesthesiology ·Talmage D. Egan, Charles F. Minto, David Hermann, Juliana Barr, Keith T. Muir, Steven L. Shafer	1996	331
5	Measured Context-sensitive Half-times of Remifentanil and Alfentanil Anesthesiology ·Atul Kapila, Peter S. A. Glass, James Jacobs, Keith T. Muir, David Hermann, Masa Shiraishi, Scott Howell, Richard L. Smith	1995	318
6	A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis Nature Medicine ·Marjorie Z. Imperial, Payam Nahid, Patrick Phillips, Geraint Davies, Katherine Fielding, Debra Hanna, David Hermann, Robert S. Wallis, John L. Johnson, Christian Lienhardt, Rada Savic	2018	191
7	Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR Journal of Pharmacology and Experimental Therapeutics ·H. Neal Bramson, David Hermann, Kenneth W. Batchelor, Frank W. Lee, Michael K. James, Stephen V. Frye	1997	116
8	How Modeling and Simulation Have Enhanced Decision Making in New Drug Development Journal of Pharmacokinetics and Pharmacodynamics ·Raymond Miller, Wayne Ewy, Brian Corrigan, Danièle Ouellet, David Hermann, Kenneth G. Kowalski, Peter Lockwood, Jeffrey R. Koup, Sean D. Donevan, Ayman El‐Kattan, Cheryl S. W. Li, John L. Werth, Douglas E. Feltner, Richard L. Lalonde	2005	99
9	Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil Survey of Anesthesiology ·Charles F. Minto, Thomas W. Schnider, Talmage D. Egan, Elizabeth Youngs, HARRYJ M. LEMMENS, Pedro L. Gambús, V. Billard, John F. Hoke, Katherine H. Moore, David Hermann, Keith T. Muir, Jaap W. Mandema, Steven L. Shafer, George F. Rich	1997	67
10	Determination of the Potency of Remifentanil Compared with Alfentanil Using Ventilatory Depression as the Measure of Opioid Effect Anesthesiology ·Peter S. A. Glass, Irène A. Iselin-Chaves, David K. Goodman, Elizabeth R. DeLong, David Hermann	1999	58
11	DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease Platelets ·Stan Heptinstall, David Iyú, Panagiotis Manolopoulos, Jackie R. Glenn, Ann E. White, Andrew J. Johnson, Natalia Dovlatova, Sue Fox, Jane May, David Hermann, Ólafur Þ. Magnússon, Hreinn Stefánsson, Dan Hartman, Mark E. Gurney	2008	55
12	Model-based development of gemcabene, a new lipid-altering agent The AAPS Journal ·Jaap W. Mandema, David Hermann, Wen‐Ping Wang, Tim Sheiner, Mark A. Milad, Rebecca Bakker‐Arkema, Daniel Hartman	2005	53
13	Influence of Gastrointestinal Site of Drug Delivery on the Absorption Characteristics of Ranitidine Pharmaceutical Research ·Melissa F. Williams, George E. Dukes, William D. Heizer, Yong Han, David Hermann, Thomas A. Lampkin, Lawrence J. Hak	1992	53
14	The Effects of Aldosterone Synthase Inhibition on Aldosterone and Cortisol in Patients With Hypertension: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Study Journal of Clinical Hypertension ·Karl Andersen, Daniel Hartman, Thomas Peppard, David Hermann, Peter Van Ess, Martin Lefkowitz, Angelo J. Trapani	2012	49
15	A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride Clinical Pharmacology & Therapeutics ·Per Olsson, David Hermann, Margareta Hammarlund‐Udenaes, Mats O. Karlsson	1998	48
16	The Effect of Caffeine on Intraocuular Pressure in Glaucoma Patents Ophthalmology ·Eve J. Higginbotham, Heidi A. Kilimanjaro, Jacob T. Wilensky, Randal L. Batenhorst, David Hermann	1989	47
17	Month 2 Culture Status and Treatment Duration as Predictors of Recurrence in Pulmonary Tuberculosis: Model Validation and Update PLoS ONE ·Robert S. Wallis, Thomas Peppard, David Hermann	2015	42
18	The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination British Journal of Clinical Pharmacology ·Per Olsson, David Hermann, Margareta Hammarlund‐Udenaes, Mats O. Karlsson	1999	38
19	Pharmacokinetics of Ondansetron in Patients with Hepatic Insufficiency The Journal of Clinical Pharmacology ·William D. Figg, George E. Dukes, J. Fred Pritchard, David Hermann, Henry R. Lesesne, Stanley W. Carson, Stephen Songer, J. Robert Powell, Lawrence J. Hak	1996	36
20	Measured Context-Sensitive Half-Times of Remifentanil and Alfentanil Survey of Anesthesiology ·Atul Kapila, PSA Glass, James Jacobs, Keith T. Muir, David Hermann, M Shiraishi, Scott Howell, R. L. Smith	1996	31

About David Hermann

David Hermann is a scholar working on Anesthesiology and Pain Medicine, Urology, Critical Care and Intensive Care Medicine, Pharmacology and Infectious Diseases, having authored 46 papers that have together received 3.6k indexed citations. Recurring topics across this work include Anesthesia and Sedative Agents (8 papers), Tuberculosis Research and Epidemiology (8 papers), Hormonal and reproductive studies (6 papers), Urinary Bladder and Prostate Research (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Intensive Care Unit Cognitive Disorders (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (1.9k citations), Developmental Neuroscience (699 citations), Critical Care and Intensive Care Medicine (574 citations), Urology (363 citations) and Surgery (1.1k citations). David Hermann has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Keith T. Muir, Steven L. Shafer, Talmage D. Egan, Harry J. M. Lemmens, Charles F. Minto, Jaap W. Mandema, Thomas W. Schnider, Elizabeth Youngs, John F. Hoke and Pedro L. Gambús. Their work appears in journals such as Anesthesiology, Journal of Pharmacokinetics and Pharmacodynamics, Nature Medicine, Combinatorial Chemistry & High Throughput Screening and CPT Pharmacometrics & Systems Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact